Global Lower Back Pain Drug Market Research Report 2024

Report ID: 1840613 | Published Date: Sep 2024 | No. of Page: 94 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Lower Back Pain Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Acute Drug
        1.2.3 Chronic Drug
    1.3 Market by Application
        1.3.1 Global Lower Back Pain Drug Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Lower Back Pain Drug Market Perspective (2017-2028)
    2.2 Lower Back Pain Drug Growth Trends by Region
        2.2.1 Lower Back Pain Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Lower Back Pain Drug Historic Market Size by Region (2017-2022)
        2.2.3 Lower Back Pain Drug Forecasted Market Size by Region (2023-2028)
    2.3 Lower Back Pain Drug Market Dynamics
        2.3.1 Lower Back Pain Drug Industry Trends
        2.3.2 Lower Back Pain Drug Market Drivers
        2.3.3 Lower Back Pain Drug Market Challenges
        2.3.4 Lower Back Pain Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Lower Back Pain Drug Players by Revenue
        3.1.1 Global Top Lower Back Pain Drug Players by Revenue (2017-2022)
        3.1.2 Global Lower Back Pain Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Lower Back Pain Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Lower Back Pain Drug Revenue
    3.4 Global Lower Back Pain Drug Market Concentration Ratio
        3.4.1 Global Lower Back Pain Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Lower Back Pain Drug Revenue in 2021
    3.5 Lower Back Pain Drug Key Players Head office and Area Served
    3.6 Key Players Lower Back Pain Drug Product Solution and Service
    3.7 Date of Enter into Lower Back Pain Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Lower Back Pain Drug Breakdown Data by Type
    4.1 Global Lower Back Pain Drug Historic Market Size by Type (2017-2022)
    4.2 Global Lower Back Pain Drug Forecasted Market Size by Type (2023-2028)
5 Lower Back Pain Drug Breakdown Data by Application
    5.1 Global Lower Back Pain Drug Historic Market Size by Application (2017-2022)
    5.2 Global Lower Back Pain Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Lower Back Pain Drug Market Size (2017-2028)
    6.2 North America Lower Back Pain Drug Market Size by Country (2017-2022)
    6.3 North America Lower Back Pain Drug Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Lower Back Pain Drug Market Size (2017-2028)
    7.2 Europe Lower Back Pain Drug Market Size by Country (2017-2022)
    7.3 Europe Lower Back Pain Drug Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Lower Back Pain Drug Market Size (2017-2028)
    8.2 Asia-Pacific Lower Back Pain Drug Market Size by Country (2017-2022)
    8.3 Asia-Pacific Lower Back Pain Drug Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Lower Back Pain Drug Market Size (2017-2028)
    9.2 Latin America Lower Back Pain Drug Market Size by Country (2017-2022)
    9.3 Latin America Lower Back Pain Drug Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Lower Back Pain Drug Market Size (2017-2028)
    10.2 Middle East & Africa Lower Back Pain Drug Market Size by Country (2017-2022)
    10.3 Middle East & Africa Lower Back Pain Drug Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Lower Back Pain Drug Introduction
        11.1.4 Pfizer Revenue in Lower Back Pain Drug Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Johnson and Johnson
        11.2.1 Johnson and Johnson Company Detail
        11.2.2 Johnson and Johnson Business Overview
        11.2.3 Johnson and Johnson Lower Back Pain Drug Introduction
        11.2.4 Johnson and Johnson Revenue in Lower Back Pain Drug Business (2017-2022)
        11.2.5 Johnson and Johnson Recent Development
    11.3 Sanofi
        11.3.1 Sanofi Company Detail
        11.3.2 Sanofi Business Overview
        11.3.3 Sanofi Lower Back Pain Drug Introduction
        11.3.4 Sanofi Revenue in Lower Back Pain Drug Business (2017-2022)
        11.3.5 Sanofi Recent Development
    11.4 Endo Pharmaceuticals
        11.4.1 Endo Pharmaceuticals Company Detail
        11.4.2 Endo Pharmaceuticals Business Overview
        11.4.3 Endo Pharmaceuticals Lower Back Pain Drug Introduction
        11.4.4 Endo Pharmaceuticals Revenue in Lower Back Pain Drug Business (2017-2022)
        11.4.5 Endo Pharmaceuticals Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Lower Back Pain Drug Introduction
        11.5.4 Merck Revenue in Lower Back Pain Drug Business (2017-2022)
        11.5.5 Merck Recent Development
    11.6 Dr. Reddy’s Laboratories
        11.6.1 Dr. Reddy’s Laboratories Company Detail
        11.6.2 Dr. Reddy’s Laboratories Business Overview
        11.6.3 Dr. Reddy’s Laboratories Lower Back Pain Drug Introduction
        11.6.4 Dr. Reddy’s Laboratories Revenue in Lower Back Pain Drug Business (2017-2022)
        11.6.5 Dr. Reddy’s Laboratories Recent Development
    11.7 Vertebral Technologies
        11.7.1 Vertebral Technologies Company Detail
        11.7.2 Vertebral Technologies Business Overview
        11.7.3 Vertebral Technologies Lower Back Pain Drug Introduction
        11.7.4 Vertebral Technologies Revenue in Lower Back Pain Drug Business (2017-2022)
        11.7.5 Vertebral Technologies Recent Development
    11.8 Medtronic
        11.8.1 Medtronic Company Detail
        11.8.2 Medtronic Business Overview
        11.8.3 Medtronic Lower Back Pain Drug Introduction
        11.8.4 Medtronic Revenue in Lower Back Pain Drug Business (2017-2022)
        11.8.5 Medtronic Recent Development
    11.9 Boston Scientific
        11.9.1 Boston Scientific Company Detail
        11.9.2 Boston Scientific Business Overview
        11.9.3 Boston Scientific Lower Back Pain Drug Introduction
        11.9.4 Boston Scientific Revenue in Lower Back Pain Drug Business (2017-2022)
        11.9.5 Boston Scientific Recent Development
    11.10 BioWave
        11.10.1 BioWave Company Detail
        11.10.2 BioWave Business Overview
        11.10.3 BioWave Lower Back Pain Drug Introduction
        11.10.4 BioWave Revenue in Lower Back Pain Drug Business (2017-2022)
        11.10.5 BioWave Recent Development
    11.11 Koninklijke Philips
        11.11.1 Koninklijke Philips Company Detail
        11.11.2 Koninklijke Philips Business Overview
        11.11.3 Koninklijke Philips Lower Back Pain Drug Introduction
        11.11.4 Koninklijke Philips Revenue in Lower Back Pain Drug Business (2017-2022)
        11.11.5 Koninklijke Philips Recent Development
    11.12 Stayble Therapeutics
        11.12.1 Stayble Therapeutics Company Detail
        11.12.2 Stayble Therapeutics Business Overview
        11.12.3 Stayble Therapeutics Lower Back Pain Drug Introduction
        11.12.4 Stayble Therapeutics Revenue in Lower Back Pain Drug Business (2017-2022)
        11.12.5 Stayble Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Lower Back Pain Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Acute Drug
    Table 3. Key Players of Chronic Drug
    Table 4. Global Lower Back Pain Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Lower Back Pain Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Lower Back Pain Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Lower Back Pain Drug Market Share by Region (2017-2022)
    Table 8. Global Lower Back Pain Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Lower Back Pain Drug Market Share by Region (2023-2028)
    Table 10. Lower Back Pain Drug Market Trends
    Table 11. Lower Back Pain Drug Market Drivers
    Table 12. Lower Back Pain Drug Market Challenges
    Table 13. Lower Back Pain Drug Market Restraints
    Table 14. Global Lower Back Pain Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Lower Back Pain Drug Market Share by Players (2017-2022)
    Table 16. Global Top Lower Back Pain Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lower Back Pain Drug as of 2021)
    Table 17. Ranking of Global Top Lower Back Pain Drug Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Lower Back Pain Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Lower Back Pain Drug Product Solution and Service
    Table 21. Date of Enter into Lower Back Pain Drug Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Lower Back Pain Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Lower Back Pain Drug Revenue Market Share by Type (2017-2022)
    Table 25. Global Lower Back Pain Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Lower Back Pain Drug Revenue Market Share by Type (2023-2028)
    Table 27. Global Lower Back Pain Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Lower Back Pain Drug Revenue Market Share by Application (2017-2022)
    Table 29. Global Lower Back Pain Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Lower Back Pain Drug Revenue Market Share by Application (2023-2028)
    Table 31. North America Lower Back Pain Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Lower Back Pain Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Lower Back Pain Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Lower Back Pain Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Lower Back Pain Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Lower Back Pain Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Lower Back Pain Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Lower Back Pain Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Lower Back Pain Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Lower Back Pain Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Pfizer Company Detail
    Table 42. Pfizer Business Overview
    Table 43. Pfizer Lower Back Pain Drug Product
    Table 44. Pfizer Revenue in Lower Back Pain Drug Business (2017-2022) & (US$ Million)
    Table 45. Pfizer Recent Development
    Table 46. Johnson and Johnson Company Detail
    Table 47. Johnson and Johnson Business Overview
    Table 48. Johnson and Johnson Lower Back Pain Drug Product
    Table 49. Johnson and Johnson Revenue in Lower Back Pain Drug Business (2017-2022) & (US$ Million)
    Table 50. Johnson and Johnson Recent Development
    Table 51. Sanofi Company Detail
    Table 52. Sanofi Business Overview
    Table 53. Sanofi Lower Back Pain Drug Product
    Table 54. Sanofi Revenue in Lower Back Pain Drug Business (2017-2022) & (US$ Million)
    Table 55. Sanofi Recent Development
    Table 56. Endo Pharmaceuticals Company Detail
    Table 57. Endo Pharmaceuticals Business Overview
    Table 58. Endo Pharmaceuticals Lower Back Pain Drug Product
    Table 59. Endo Pharmaceuticals Revenue in Lower Back Pain Drug Business (2017-2022) & (US$ Million)
    Table 60. Endo Pharmaceuticals Recent Development
    Table 61. Merck Company Detail
    Table 62. Merck Business Overview
    Table 63. Merck Lower Back Pain Drug Product
    Table 64. Merck Revenue in Lower Back Pain Drug Business (2017-2022) & (US$ Million)
    Table 65. Merck Recent Development
    Table 66. Dr. Reddy’s Laboratories Company Detail
    Table 67. Dr. Reddy’s Laboratories Business Overview
    Table 68. Dr. Reddy’s Laboratories Lower Back Pain Drug Product
    Table 69. Dr. Reddy’s Laboratories Revenue in Lower Back Pain Drug Business (2017-2022) & (US$ Million)
    Table 70. Dr. Reddy’s Laboratories Recent Development
    Table 71. Vertebral Technologies Company Detail
    Table 72. Vertebral Technologies Business Overview
    Table 73. Vertebral Technologies Lower Back Pain Drug Product
    Table 74. Vertebral Technologies Revenue in Lower Back Pain Drug Business (2017-2022) & (US$ Million)
    Table 75. Vertebral Technologies Recent Development
    Table 76. Medtronic Company Detail
    Table 77. Medtronic Business Overview
    Table 78. Medtronic Lower Back Pain Drug Product
    Table 79. Medtronic Revenue in Lower Back Pain Drug Business (2017-2022) & (US$ Million)
    Table 80. Medtronic Recent Development
    Table 81. Boston Scientific Company Detail
    Table 82. Boston Scientific Business Overview
    Table 83. Boston Scientific Lower Back Pain Drug Product
    Table 84. Boston Scientific Revenue in Lower Back Pain Drug Business (2017-2022) & (US$ Million)
    Table 85. Boston Scientific Recent Development
    Table 86. BioWave Company Detail
    Table 87. BioWave Business Overview
    Table 88. BioWave Lower Back Pain Drug Product
    Table 89. BioWave Revenue in Lower Back Pain Drug Business (2017-2022) & (US$ Million)
    Table 90. BioWave Recent Development
    Table 91. Koninklijke Philips Company Detail
    Table 92. Koninklijke Philips Business Overview
    Table 93. Koninklijke Philips Lower Back Pain DrugProduct
    Table 94. Koninklijke Philips Revenue in Lower Back Pain Drug Business (2017-2022) & (US$ Million)
    Table 95. Koninklijke Philips Recent Development
    Table 96. Stayble Therapeutics Company Detail
    Table 97. Stayble Therapeutics Business Overview
    Table 98. Stayble Therapeutics Lower Back Pain DrugProduct
    Table 99. Stayble Therapeutics Revenue in Lower Back Pain Drug Business (2017-2022) & (US$ Million)
    Table 100. Stayble Therapeutics Recent Development
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Lower Back Pain Drug Market Share by Type: 2021 VS 2028
    Figure 2. Acute Drug Features
    Figure 3. Chronic Drug Features
    Figure 4. Global Lower Back Pain Drug Market Share by Application in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Other Case Studies
    Figure 8. Lower Back Pain Drug Report Years Considered
    Figure 9. Global Lower Back Pain Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Lower Back Pain Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Lower Back Pain Drug Market Share by Region: 2021 VS 2028
    Figure 12. Global Lower Back Pain Drug Market Share by Players in 2021
    Figure 13. Global Top Lower Back Pain Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lower Back Pain Drug as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Lower Back Pain Drug Revenue in 2021
    Figure 15. North America Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Lower Back Pain Drug Market Share by Country (2017-2028)
    Figure 17. United States Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Lower Back Pain Drug Market Share by Country (2017-2028)
    Figure 21. Germany Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Lower Back Pain Drug Market Share by Region (2017-2028)
    Figure 29. China Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Lower Back Pain Drug Market Share by Country (2017-2028)
    Figure 37. Mexico Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Lower Back Pain Drug Market Share by Country (2017-2028)
    Figure 41. Turkey Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Lower Back Pain Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Pfizer Revenue Growth Rate in Lower Back Pain Drug Business (2017-2022)
    Figure 44. Johnson and Johnson Revenue Growth Rate in Lower Back Pain Drug Business (2017-2022)
    Figure 45. Sanofi Revenue Growth Rate in Lower Back Pain Drug Business (2017-2022)
    Figure 46. Endo Pharmaceuticals Revenue Growth Rate in Lower Back Pain Drug Business (2017-2022)
    Figure 47. Merck Revenue Growth Rate in Lower Back Pain Drug Business (2017-2022)
    Figure 48. Dr. Reddy’s Laboratories Revenue Growth Rate in Lower Back Pain Drug Business (2017-2022)
    Figure 49. Vertebral Technologies Revenue Growth Rate in Lower Back Pain Drug Business (2017-2022)
    Figure 50. Medtronic Revenue Growth Rate in Lower Back Pain Drug Business (2017-2022)
    Figure 51. Boston Scientific Revenue Growth Rate in Lower Back Pain Drug Business (2017-2022)
    Figure 52. BioWave Revenue Growth Rate in Lower Back Pain Drug Business (2017-2022)
    Figure 53. Koninklijke Philips Revenue Growth Rate in Lower Back Pain Drug Business (2017-2022)
    Figure 54. Stayble Therapeutics Revenue Growth Rate in Lower Back Pain Drug Business (2017-2022)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
    Figure 57. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Johnson and Johnson
Sanofi
Endo Pharmaceuticals
Merck
Dr. Reddy’s Laboratories
Vertebral Technologies
Medtronic
Boston Scientific
BioWave
Koninklijke Philips
Stayble Therapeutics
Frequently Asked Questions
Lower Back Pain Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Lower Back Pain Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Lower Back Pain Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

eVTOL Jet

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More